Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
This study has been terminated.
(Refer to Detailed Description for documentaion of Termination Statement.)
First Posted: May 4, 2011
Last Update Posted: January 14, 2016
Information provided by (Responsible Party):